Accretion Nutraveda Ltd

Accretion Nutraveda Investor Presentation: Key Takeaways

H1 FY27 (Apr–Sep 2026): revenue ₹29.44 Cr (+109.35% YoY), EBITDA ₹6.26 Cr (21.27% margin), PAT ₹4.73 Cr (16.06% margin). Focus on capacity expansion and product diversification.

Accretion Nutraveda Results Update

Accretion Nutraveda released a half-year media release showing revenue up 109.35% to Rs 29.44 crore. EBITDA rose 88.03% and PAT rose 98.66%.

Accretion Nutraveda H1 FY27 Results: Net Profit ₹4.7 Cr, Up 95.8% YoY

Accretion Nutraveda Ltd reported revenue from operations of ₹29.4 Cr (+108.5% YoY) and net profit of ₹4.7 Cr (+95.8% YoY) for H1 FY27.

Key figure

Net profit ₹4.7 Cr · +95.8% YoY

Accretion Nutraveda Other Announcement

Accretion Nutraveda's quarterly shareholding pattern shows promoters holding 73.48%. The routine filing reports no corporate action or event value.

Accretion Nutraveda Board Meeting Date

Accretion Nutraveda will hold a board meeting on 31 October 2026 to consider unaudited financial results for the half year ended September 2026. The intimation is a prior notice under Regulation 29.